tiprankstipranks
Trending News
More News >
Bodycote PLC (GB:BOY)
LSE:BOY

Bodycote (BOY) AI Stock Analysis

Compare
28 Followers

Top Page

GB:BOY

Bodycote

(LSE:BOY)

Select Model
Select Model
Select Model
Neutral 62 (OpenAI - 5.2)
,
Neutral 62 (OpenAI - 5.2)
,
Neutral 62 (OpenAI - 5.2)
Rating:62Neutral
Price Target:
664.00 p
▲(6.07% Upside)
Action:ReiteratedDate:03/12/26
The score is driven primarily by mid-tier financial performance: a strong 2025 profitability rebound and a solid balance sheet are tempered by uneven revenue trends and inconsistent free cash flow conversion. Technicals are mildly supportive but not strong due to negative MACD, and valuation looks somewhat demanding despite a decent dividend yield.
Positive Factors
Balance Sheet Health
A structurally solid balance sheet with moderate leverage provides durable financial flexibility: it supports investment in service centres, absorbs cyclical downturns in industrial end markets, and allows management to fund maintenance capex or opportunistic M&A without immediate refinancing pressure.
Profitability Rebound
A material margin recovery in 2025 indicates the business retains operating leverage and the ability to restore profitability after weak periods. Sustained margin improvement strengthens free cash generation potential, supports reinvestment in higher-value processes, and underpins long-term earnings resilience.
Business Model and Market Position
A fee-for-service, networked model serving aerospace, automotive and industrial supply chains creates recurring demand and customer stickiness. High compliance, certification and capital intensity raise barriers to entry, advantaging a scaled incumbent and supporting stable structural demand over multi-year cycles.
Negative Factors
Revenue Trend Volatility
Choppy and recently negative revenue trends reduce confidence in top-line durability. For a fee-for-service industrial operator, flat-to-declining revenue constrains margin expansion and makes long-term capacity planning, pricing recovery and investment returns more uncertain across 2–6 month horizons and beyond.
Inconsistent Free Cash Flow Conversion
Inconsistent FCF and weaker conversion versus net income weaken the company’s ability to self-fund capex, dividends or strategic deals. Persistent variability increases sensitivity to working-capital swings and elevates refinancing and liquidity risk if earnings weaken again or if investment needs rise.
Earnings Power Volatility
Material historical swings in profitability signal unstable earnings power, complicating forecasting and capital allocation. Volatility undermines confidence in sustainable margins, raises the chance of future profit surprises, and can constrain strategic investments during weaker cycles.

Bodycote (BOY) vs. iShares MSCI United Kingdom ETF (EWC)

Bodycote Business Overview & Revenue Model

Company DescriptionBodycote plc provides heat treatment and thermal processing services worldwide. The company operates in two Aerospace, Defence & Energy; and Automotive & General Industrial segments. It offers heat treatment services, including altering the microstructure of metals and alloys, such as steel and aluminum to impart properties comprising surface hardness, temperature resistance, ductility, and strength; metal joining services consisting of electron beam welding, HIP diffusion bonding, hydrogen brazing, induction brazing, and vacuum and honeycomb brazing; and hot isostatic pressing (HIP) services, including isostatic pressing and HIP supporting services, as well as Powdermet technology, a manufacturing process used in the production of complex components using powder metallurgy. The company also provides surface technologies, which are used to prolong the working life of components and protect from environmental factors, such as corrosion and abrasion. Its surface technologies include anodizing, ceramic, flame and combustion spraying, high velocity oxygen fuel, plasma spray, electric arc spraying, aluminide coatings, liquid coatings, and thermo-chemically formed ceramic coatings to enhance corrosion protection and wear resistance. The company serves automotive, aerospace and defense, energy, and general industrial markets. Bodycote plc was founded in 1923 and is headquartered in Macclesfield, the United Kingdom.
How the Company Makes MoneyBodycote makes money by providing outsourced heat treatment and specialist thermal processing services to manufacturers and their supply chains, earning revenue largely on a fee-for-service basis. Key revenue streams typically include: (1) Heat treatment services performed per batch/lot or per component, where customers pay for processing parts to specified metallurgical standards (often tied to customer or industry certifications); (2) Specialist thermal processing and surface technology services, where higher-value processes (and associated quality assurance requirements) can command premium pricing; and (3) Ancillary services embedded in contracts such as testing, certification/documentation, and quality assurance activities required for regulated end markets (notably aerospace and defense). Commercially, Bodycote’s earnings are supported by long-term customer relationships and repeat demand driven by ongoing production and maintenance cycles in end markets, as well as by its scale/network model, which enables customers to outsource capital-intensive, compliance-heavy processes rather than run them in-house. Specific information on named significant partnerships is null.

Bodycote Financial Statement Overview

Summary
Overall fundamentals are mid-range: profitability rebounded sharply in 2025 after a weak 2024, and the balance sheet remains solid with moderate leverage. However, revenue has been choppy/flat and both earnings power and free cash flow conversion have been volatile, limiting confidence in consistency.
Income Statement
62
Positive
Revenue has been choppy (down in 2024 and flat in 2025), but profitability rebounded sharply in 2025 versus the depressed 2024 result, with stronger operating and net margins. Longer-term, earnings power appears volatile (notably strong in 2022–2023, weak in 2020 and 2024), which reduces confidence in the consistency of the margin structure despite the 2025 improvement.
Balance Sheet
74
Positive
The balance sheet looks solid with moderate leverage: debt remains well below equity across the period, supporting financial flexibility. A key watch-out is the upward drift in leverage from 2023 to 2025 (debt rising while equity trends lower), which modestly increases risk if profitability weakens again.
Cash Flow
58
Neutral
Cash generation is positive and operating cash flow is sizable, but free cash flow has been inconsistent and declined in 2025 (down ~16%). Free cash flow conversion is also middling (free cash flow is well below net income in 2025), pointing to less reliable cash profitability and a higher sensitivity to working-capital and investment swings.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue727.10M757.10M802.50M743.60M615.80M
Gross Profit280.80M109.30M108.10M269.70M225.70M
EBITDA179.80M124.00M201.70M186.60M167.70M
Net Income54.90M20.00M85.60M73.70M59.50M
Balance Sheet
Total Assets1.05B1.07B1.14B1.17B1.07B
Cash, Cash Equivalents and Short-Term Investments25.20M19.10M45.20M37.20M39.30M
Total Debt190.80M150.90M96.90M136.60M156.20M
Total Liabilities411.70M397.50M344.40M385.70M384.40M
Stockholders Equity640.20M668.10M790.80M780.90M684.70M
Cash Flow
Free Cash Flow58.90M82.50M109.20M70.10M87.10M
Operating Cash Flow135.30M152.60M191.60M137.10M139.10M
Investing Cash Flow-56.00M-112.80M-71.20M-62.30M-104.80M
Financing Cash Flow-71.00M-67.60M-110.20M-82.80M-30.30M

Bodycote Technical Analysis

Technical Analysis Sentiment
Negative
Last Price626.00
Price Trends
50DMA
747.64
Negative
100DMA
701.15
Negative
200DMA
657.89
Negative
Market Momentum
MACD
-26.87
Positive
RSI
35.41
Neutral
STOCH
5.73
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:BOY, the sentiment is Negative. The current price of 626 is below the 20-day moving average (MA) of 730.08, below the 50-day MA of 747.64, and below the 200-day MA of 657.89, indicating a bearish trend. The MACD of -26.87 indicates Positive momentum. The RSI at 35.41 is Neutral, neither overbought nor oversold. The STOCH value of 5.73 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:BOY.

Bodycote Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
£1.82B15.4333.12%1.01%24.42%103.25%
70
Outperform
£176.33M10.696.13%1.02%14.49%76.33%
65
Neutral
£110.87M7.633.83%6.69%-13.30%-60.03%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
62
Neutral
£1.08B22.488.58%3.30%-6.95%-52.08%
62
Neutral
£534.19M28.898.04%4.87%-7.30%-59.71%
61
Neutral
£4.81B30.7613.88%2.46%0.10%-15.33%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:BOY
Bodycote
626.00
85.07
15.73%
GB:AVG
Avingtrans
530.00
193.63
57.56%
GB:CGS
Castings
255.00
4.68
1.87%
GB:GDWN
Goodwin
24,200.00
17,738.51
274.53%
GB:MGAM
Morgan Advanced Materials
193.40
-3.99
-2.02%
GB:SPX
Spirax Group
6,525.00
-88.02
-1.33%

Bodycote Corporate Events

Business Operations and StrategyStock Buyback
Bodycote Launches £80 Million Share Buyback to Cut Capital and Boost Returns
Positive
Mar 11, 2026

Bodycote plc has launched a new share buyback programme of up to £80 million, to be completed by the end of 2027, signalling confidence in its strong balance sheet and a disciplined approach to capital allocation. The programme will be executed in two £40 million tranches, with Barclays Bank PLC mandated to repurchase and cancel up to 12,301,205 ordinary shares under current authority, reducing the company’s share capital and potentially enhancing earnings per share and shareholder value.

Under an arrangement with Barclays, the bank will act as riskless principal in purchasing Bodycote shares in compliance with UK Listing Rules and shareholder authorities, including during closed periods where trades will be conducted independently of the company. All repurchased shares will be cancelled, underlining that the sole purpose of the initiative is capital reduction rather than holding treasury stock, reinforcing Bodycote’s capital return strategy for investors.

The most recent analyst rating on (GB:BOY) stock is a Hold with a £829.00 price target. To see the full list of analyst forecasts on Bodycote stock, see the GB:BOY Stock Forecast page.

Regulatory Filings and Compliance
Bodycote Confirms Total Voting Rights at 172.8 Million Shares
Neutral
Feb 27, 2026

Bodycote plc has confirmed that, as of 27 February 2026, it has 172,762,590 ordinary shares in issue, each carrying voting rights, with none held in treasury. This disclosure clarifies the company’s current share capital structure for investors and maintains compliance with the Financial Conduct Authority’s transparency requirements.

The stated figure will serve as the denominator for shareholders when calculating whether their holdings trigger disclosure thresholds under U.K. rules on significant shareholdings. The announcement helps ensure accurate reporting of ownership changes, supporting market transparency and providing a clear reference point for institutional and retail investors monitoring their positions in Bodycote.

The most recent analyst rating on (GB:BOY) stock is a Hold with a £829.00 price target. To see the full list of analyst forecasts on Bodycote stock, see the GB:BOY Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 12, 2026